TAM
DYN icon

TFG Asset Management’s Dyne Therapeutics DYN Stock Holding History

TFG Asset Management’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.92M Buy
356,657
+98,525
+38% +$1.83M 1.25% 18
2026
Q1 		$4.68M Buy
258,132
+10,135
+4% +$175K 0.91% 19
2025
Q4 		$4.85M Buy
247,997
+24,816
+11% +$470K 1.02% 13
2025
Q3 		$2.82M Buy
223,181
+84,806
+61% +$967K 0.38% 26
2025
Q2 		$1.32M Buy
+138,375
New +$1.52M 0.21% 30

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

TFG Asset Management's DYN Position: Q2 2026 in Review

TFG Asset Management increased its Dyne Therapeutics (DYN) stake by 38% in Q2 2026, buying an estimated $1.83M and bringing the position to 356,657 shares worth $7.92M. The position accounts for 1.25% of the portfolio, ranked #18.

TFG Asset Management first reported a position in DYN in Q2 2025 and has held it in 5 quarters since. 245 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • TFG Asset Management held 356,657 shares of Dyne Therapeutics worth $7.92M as of Q2 2026.
  • TFG Asset Management bought 98,525 Dyne Therapeutics shares in Q2 2026, an estimated $1.83M.
  • Dyne Therapeutics made up 1.25% of TFG Asset Management's portfolio in Q2 2026, its #18 holding.
  • TFG Asset Management first reported a position in Dyne Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 245 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on TFG Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.